InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.33
(
0.48%
)
Bitcoin
58,107.01
(
-3.42%
)
Post# of 1198
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

LexTrader

Send PM Follow Ignore
Followers 241
Posts 21217
Boards Moderated 0
Alias Born 08/10/2000

LexTrader

Member Level

Re: None

Tuesday, 12/13/2022 8:03:23 AM

Tuesday, December 13, 2022 8:03:23 AM

Post# of 1198
A new Moderna cancer vaccine, when paired with Merck's Keytruda, produced a positive clinical outcome in a mid-stage trial, the company announced this morning.

The drug combination provided a statistically significant result in stopping the recurrence of the skin cancer melanoma after surgery in patients, the Wall Street Journal reported on Tuesday morning.

The news sent Moderna shares soaring higher by more than 7% in early morning trading.
https://www.zerohedge.com/markets/moderna-soars-after-cancer-vaccine-collab-merck-meets-primary-endpoint-phase-2b-trial

Hmmmm. wonder what will be in this one?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up